Literature DB >> 31812020

Associations of plasma metal concentrations with the decline in kidney function: A longitudinal study of Chinese adults.

Yiyi Liu1, Yu Yuan2, Yang Xiao1, Yizhun Li1, Yanqiu Yu1, Tingting Mo1, Haijing Jiang1, Xiulou Li3, Handong Yang3, Chengwei Xu3, Meian He1, Huan Guo1, An Pan4, Tangchun Wu1.   

Abstract

Metals are widespread pollutants in the environment which have been reported to be associated with kidney dysfunction in many existing epidemiological studies. However, most of the studies are cross-sectional design and mainly focus on several toxic metals including arsenic, lead and cadmium. Therefore, we conducted this prospective study within the Dongfeng-Tongji cohort to evaluate the associations of plasma multiple metals with the decline in kidney function among Chinese middle-aged and elderly. In total, 1434 participants free of chronic diseases at baseline were included in analysis. We measured baseline plasma concentrations of 23 metals and calculated estimated glomerular filtration rate (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation based on serum creatinine, age, sex and ethnicity. Bonferroni correction was used for multiple testing to reduce the probability of a type I error. Principal component analysis was conducted to evaluate the combined effect of multiple metal co-exposure. Most of the plasma metal concentrations were within the literature reported reference values, whereas the concentration of lead and nickel exceeded the guideline value. We found that plasma concentrations of aluminum, arsenic, barium, lead, molybdenum, rubidium, strontium, vanadium and zinc were significantly associated with the decline in kidney function measured by annual eGFR decline, rapid renal function decline (defined as an annual decline in eGFR ≥ 5 mL/min/1.73 m2) or incident eGFR < 60 mL/min/1.73 m2, with the adjusted beta coefficients (95% CI) for annual eGFR decline 0.50 (0.30, 0.69), 0.98 (0.74, 1.23), 0.56 (0.32, 0.79), 0.21 (0.03, 0.39), 0.35 (0.16, 0.54), 0.94 (0.71, 1.17), 0.37 (0.15, 0.60), 0.78 (0.54, 1.02), and 0.74 (0.57, 0.91), respectively. The metals exposures were linked with increased risks of impaired kidney function. Associations of principal components representing these metals with the decline in kidney function were significant and suggest a possible additional health risk by co-exposure. Participants engaged in manufacturing had higher plasma levels of several metals compared with those who had been involved in management- or administration-related work. Our findings suggest that exposure to multiple metals contribute to the decline in kidney function among the middle-aged and elderly. Co-exposure to multiple metals may have synergetic effect on the kidney function. Further studies are warranted to confirm our findings and clarify the potential mechanisms.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Kidney function; Metals; Principal component analysis; Prospective study

Mesh:

Substances:

Year:  2019        PMID: 31812020     DOI: 10.1016/j.ecoenv.2019.110006

Source DB:  PubMed          Journal:  Ecotoxicol Environ Saf        ISSN: 0147-6513            Impact factor:   6.291


  9 in total

1.  Associations between essential microelements exposure and the aggressive clinicopathologic characteristics of papillary thyroid cancer.

Authors:  Ming-Jun Hu; Jia-Liu He; Xin-Ran Tong; Wan-Jun Yang; Huan-Huan Zhao; Guo-Ao Li; Fen Huang
Journal:  Biometals       Date:  2021-05-07       Impact factor: 2.949

2.  Chronic Exposure to Cadmium Induces Differential Methylation in Mice Spermatozoa.

Authors:  Wesley N Saintilnord; Sara Y N Tenlep; Joshua D Preston; Eleonora Duregon; Jason E DeRouchey; Jason M Unrine; Rafael de Cabo; Kevin J Pearson; Yvonne N Fondufe-Mittendorf
Journal:  Toxicol Sci       Date:  2021-04-12       Impact factor: 4.849

3.  Combined effects of nucleotide-binding domain-like receptor protein 3 polymorphisms and environmental metals exposure on chronic kidney disease.

Authors:  Yu-Mei Hsueh; Wei-Jen Chen; Ying-Chin Lin; Ya-Li Huang; Horng-Sheng Shiue; Yuh-Feng Lin; Ru-Lan Hsieh; Hsi-Hsien Chen
Journal:  Sci Rep       Date:  2022-04-15       Impact factor: 4.996

Review 4.  Environmental Pollution and Chronic Kidney Disease.

Authors:  Hui-Ju Tsai; Pei-Yu Wu; Jiun-Chi Huang; Szu-Chia Chen
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

5.  The Association Between Cadmium Exposure and Osteoporosis: A Longitudinal Study and Predictive Model in a Chinese Female Population.

Authors:  Miaomiao Wang; Xinru Wang; Jingjing Liu; Zhongqiu Wang; Taiyi Jin; Guoying Zhu; Xiao Chen
Journal:  Front Public Health       Date:  2021-11-29

6.  The Association of Renal Function and Plasma Metals Modified by EGFR and TNF-α Gene Polymorphisms in Metal Industrial Workers and General Population.

Authors:  Tzu-Hua Chen; Joh-Jong Huang; Hsiang-Ying Lee; Wei-Shyang Kung; Kuei-Hau Luo; Jia-Yi Lu; Hung-Yi Chuang
Journal:  Int J Environ Res Public Health       Date:  2021-08-25       Impact factor: 3.390

7.  Plasma Vitamin B12 and Folate Alter the Association of Blood Lead and Cadmium and Total Urinary Arsenic Levels with Chronic Kidney Disease in a Taiwanese Population.

Authors:  Yu-Mei Hsueh; Ya-Li Huang; Yuh-Feng Lin; Horng-Sheng Shiue; Ying-Chin Lin; Hsi-Hsien Chen
Journal:  Nutrients       Date:  2021-10-28       Impact factor: 5.717

8.  Metals and Metallothionein Expression in Relation to Progression of Chronic Kidney Disease of Unknown Etiology (CKDu) in Sri Lanka.

Authors:  S H Nandana P Gunawickrama; A Rajith N Silva; P G Chandra L Nanayakkara; K B Suneetha Gunawickrama; J M Kithsiri B Jayasekara; Naduviladath V Chandrasekharan
Journal:  Diseases       Date:  2022-06-12

9.  Analysis of Threshold Effect of Urinary Heavy Metal Elements on the High Prevalence of Nephrolithiasis in Men.

Authors:  Yalan Liu; Cailiang Zhang; Zixiu Qin; Qianyuan Yang; Juan Lei; Xuejie Tang; Qiaorong Wang; Feng Hong
Journal:  Biol Trace Elem Res       Date:  2021-07-14       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.